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Invading viral DNA can be recognized by the host
cytosolic DNA sensor, cyclic GMP-AMP (cGAMP)
synthase (cGAS), resulting in production of the sec-
ond messenger cGAMP, which directs the adaptor
protein STING to stimulate production of type I inter-
ferons (IFNs). Although several DNA viruses are
sensed by cGAS, viral strategies targeting cGAS
are virtually unknown. We report here that Kaposi’s
sarcoma-associated herpesvirus (KSHV) ORF52, an
abundant gammaherpesvirus-specific tegument
protein, subverts cytosolic DNA sensing by directly
inhibiting cGAS enzymatic activity through a mecha-
nism involving both cGAS binding and DNA binding.
Moreover, ORF52 homologs in other gammaherpes-
viruses also inhibit cGAS activity and similarly bind
cGAS and DNA, suggesting conserved inhibitory
mechanisms. Furthermore, KSHV infection evokes
cGAS-dependent responses that can limit the infec-
tion, and an ORF52 null mutant exhibits increased
cGAS signaling. Our findings reveal a mechanism
through which gammaherpesviruses antagonize
host cGAS DNA sensing.
INTRODUCTION
Cytosolic DNA derived from microbial pathogens represents
a potent pathogen-associated molecular pattern (PAMP) that
triggers the host innate immune responses by stimulating
production of type I interferons (IFNs). The cyclic guanosine
monophosphate-adenosine monophosphate (cGAMP) synthase
(cGAS) has recently been identified as the principal sensor of
cytosolic DNA (Cai et al., 2014; Sun et al., 2013; Wu et al.,
2013). Binding of DNA to cGAS activates its enzymatic activity,
producing cGAMP from ATP and GTP (Cai et al., 2014; Civril
et al., 2013; Gao et al., 2013b; Kranzusch et al., 2013; Li et al.,Cell Host &2013a; Zhang et al., 2014). As a second messenger, cGAMP
binds to and activates the stimulator of interferon genes (STING)
in infected cells, as well as neighboring cells, through cell-cell
junctions (Ablasser et al., 2013a, 2013b; Gao et al., 2013c).
Active STING then activates TANK-binding kinase 1 (TBK1) to
phosphorylate and activate interferon regulatory factor 3
(IRF3), ultimately leading to expression of type I IFNs (Barber,
2014; Tanaka and Chen, 2012). DNA viruses, including herpes
simplex virus 1 (HSV-1), vaccinia virus, and adenovirus, as well
as retroviruses, such as HIV-1, have been shown to be sensed
by cGAS (Dai et al., 2014; Gao et al., 2013a; Lam et al., 2014;
Li et al., 2013b). Because activation of cGAS elicits a potent anti-
viral response (Li et al., 2013b; Schoggins et al., 2014), viruses
must possess mechanisms to subvert the cGAS-cGAMP
signaling pathway to establish successful infection. To date, no
such mechanisms have been described.
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the
causative agent of Kaposi’s sarcoma (KS), primary effusion
lymphoma, and a subset of multicentric Castleman’s disease
(Cesarman et al., 1995; Chang et al., 1994; Ganem, 2007; Soulier
et al., 1995). Like other herpesviruses, KSHV exhibits two alter-
native life cycles: latent and lytic. KSHV primarily establishes
latency, during which only a handful of genes are expressed
and no progeny are produced. Lytic replication constitutes
expression of the full complement of viral genes in a temporal
cascade, ultimately resulting in the production of progeny virions
(Ganem, 2007). A low level of spontaneous lytic reactivation
occurs in the lesions of KSHV-associated diseases, and is
believed to be required for viral persistence and pathogenesis
(Ganem, 2010). Although the capsid-enclosed herpesviral DNA
is believed to be delivered into the nucleus, where herpesviruses
replicate their genomes, viral DNA could leak into the cytosol and
subsequently be sensed by cGAS (Horan et al., 2013; Paludan
et al., 2011). It is thus possible that KSHV infection could elicit
cGAS-dependent responses and that the virus possesses a
mechanism(s) to subvert cGAS-cGAMP signaling in order to
evade the innate immune response. However, no viral strategies
that target cGAS have been described. We report here that
KSHV ORF52, a gammaherpesvirus-specific tegument protein,
inhibited cGAS enzymatic activity via a mechanism involving itsMicrobe 18, 333–344, September 9, 2015 ª2015 Elsevier Inc. 333
binding to DNA and cGAS. Furthermore, ORF52 homologs
in other gammaherpesviruses also inhibited cGAS. Moreover,
we found that KSHV primary infection elicits cGAS- and
STING-dependent responses that can be partially mitigated
by ORF52. Our results reveal KSHV ORF52 as an inhibitor of
cGAS, and we propose to name it KSHV inhibitor of cGAS,
KicGAS.
RESULTS
KSHV ORF52 Inhibits cGAS DNA-Sensing Signaling
We reasoned that a potential cGAS inhibitor would be a virion
component, localize to the cytoplasm, and interact with DNA
and/or cGAS. Systematic analysis of all KSHV proteins for
inhibition of cGAS-dependent IFNb production revealed eight
viral protein candidates as cGAS signaling antagonists (see
Figure S1A available online). Among them, ORF52 was the only
protein confirmed to bind to DNA (Figures S1B and S1C).
ORF52 was previously shown to be an abundant virion protein
(Zhu et al., 2005) and localize exclusively to the cytoplasm
(Sander et al., 2008), making it a prime candidate for an inhibitor
of cGAS. To determine whether ORF52 has an effect on the
cGAS signaling pathway, we coexpressed cGAS with IFNb lucif-
erase reporter in the presence or absence of ORF52 in HEK293T
cells stably expressing STING (HEK293T/STING). Transfection
of cGAS increased IFNb promoter-driven luciferase activity by
more than 150-fold, but coexpression with ORF52 reduced
cGAS-induced luciferase activity by more than 80% (Figure 1A).
The inhibition appeared to be specific to cGAS, because ORF52
had little effect on luciferase activity induced by the cytosolic
RNA sensor RIG-I (Figure 1A). In agreement with the inhibition
of luciferase reporter activity, cGAS-mediated dimerization and
phosphorylation of IRF3 were inhibited by ORF52 (Figure 1B) in
a dose-dependent manner (Figure S2A). Furthermore, while
HEK293T/STING cells expressing cGAS displayed a strong
antiviral effect to vesicular stomatitis virus (VSV-GFP) infection
(14.7% infection), coexpression with ORF52 partially relieved
this effect (53.5% infection), suggesting that ORF52 specifically
inhibits cGAS-dependent antiviral responses (Figure 1C).
The human monocyte cell line THP-1 expresses most cyto-
solic DNA sensors and has been used extensively for their study
(Sun et al., 2013; Wu et al., 2013; Zhang et al., 2011). We made
use of the reporter cell line THP1 Lucia ISG (Invivogen), which
expresses luciferase from a gene under the control of an IRF3-
inducible ISG54 promoter, as a surrogate assay to measure
induction of the innate immune response by nucleic acid sen-
sors. We transduced these cells with a lentiviral vector express-
ing ORF52 from a doxycycline-inducible promoter or with control
empty vector (pEasiLV). We found that expression of ORF52
reduced luciferase activity induced by interferon stimulatory
DNA 45-mer (ISD45), but not by RNA Poly(I:C) (Figure 1D).
ORF52 expression also reduced the dimerization and phosphor-
ylation of IRF3, confirming its specific inhibition of DNA- but not
RNA-induced activation of IRF3 (Figure 1E). Similarly, ORF52
also reduced luciferase activity induced by the DNA virus
vaccinia (VACV), but not by the RNA virus Sendai (SEV) (Fig-
ure 1F), in a dose-dependent manner (Figure S2B). Furthermore,
purified ORF52 protein directly transfected after fusion with
TAT cell-penetrating peptide (Figures S2C–S2E) also inhibited334 Cell Host & Microbe 18, 333–344, September 9, 2015 ª2015 ElsDNA- but not RNA-dependent responses, further confirming
our previous results (Figures 1G–1I). Together, these data sug-
gest that KSHV ORF52 selectively inhibits cGAS DNA-sensing
signaling.
ORF52 Inhibits cGAS Enzymatic Activity
Although ORF52 inhibited DNA- and cGAS-triggered dimeriza-
tion and phosphorylation of IRF3, it had no apparent effect on
cGAMP-induced activation of IRF3 (Figures 2A and 2B), suggest-
ing that ORF52 inhibits cGAS directly. Because cGAS catalyzes
synthesis of cGAMP upon binding to DNA, we examined the ef-
fect of ORF52 protein on cGAS enzymatic activity.We expressed
humancGAS (hcGAS) andORF52 inbacteria andpurified them to
homogeneity (Figure 2C). The purified hcGAS catalyzed the pro-
duction of cGAMP only when ISD45was included in the reaction.
Approximately 70% of [a-32P]-ATP was converted to cGAMP in
2 hr under our assay conditions (Figure 2D). Inclusion of ORF52
in the reaction reduced production of cGAMP in a dose-depen-
dent manner, from 40% at an ORF52:cGAS molar ratio of 1:1
to complete inhibition at a ratio of 4:1 (Figures 2D and 2E). We
found that ORF52 could also inhibit the enzymatic activity of
mouse cGAS (mcGAS) in a dose-dependent manner (Figure 2F).
These results indicate that ORF52 directly inhibits cGAS enzy-
matic activity, resulting in decreased cGAMP synthesis.
DNA Binding Is Required for ORF52 to Inhibit
cGAS Activity
Because cGAS activity depends on DNA, we performed assays
with increasing concentration of ISD (up to a DNA:cGAS molar
ratio of 30:1) in the presence or absence of ORF52 (ORF52:cGAS
of 4:1). At low-intermediate concentrations of DNA, cGAS activ-
ity was completely inhibited by ORF52 (Figure 3A). However, at
high concentrations of DNA (DNA:cGAS molar ratio of >4:1),
the inhibition of cGAS activity by ORF52 could be partially over-
come. To further quantify the effect of ORF52 on cGAS activity,
we plotted the multiple turnover reaction rate at a given cGAS
concentration against the concentration of DNA in order to
obtain the EC50 value of DNA (the concentration of DNA at
which cGAS reaches half its maximum activity). The EC50 was
significantly greater when 4 mM ORF52 was present (7.65 mM)
than when it was absent (0.05 mM) (Figure 3A), suggesting that
ORF52 may sequester DNA from cGAS.
However, cGAS apparently binds to DNAmore efficiently than
ORF52, as revealed by fluorescence polarization DNA binding
assay (Figure 3B), raising the question of whether ORF52 inhibits
cGAS activity solely through DNA binding. To address the extent
to which DNA sequestration contributes to cGAS inhibition,
we screened ORF52 mutants deficient in DNA binding, using
a DNA binding assay with dsDNA-coupled cellulose beads
(Figure 3C, upper panel). We found that one ORF52 mutant
(K68/69A) exhibited substantially reduced DNA binding ability
(Figure 3C, lower panel, lane 14). We then examined inhibition
of cGAS by ORF52-K68/69A and found that loss of DNA binding
compromised inhibition, supporting the role of DNA binding by
ORF52 in cGAS inhibition (Figure 3D).
ORF52 Interacts with cGAS
AlthoughORF52 inhibitedDNA-inducedcGAS-cGAMPsignaling,
it had little effect on DNA-induced inflammasome responsesevier Inc.
Figure 1. Inhibition of cGAS DNA-Sensing Signaling by KSHV ORF52
(A) KSHVORF52 inhibits cGAS-induced IFNb promoter activity. HEK293T-STING cells were transfectedwith IFNb luciferase reporter and expression plasmids as
indicated, and luciferase activity was assayed 24 hr after transfection. The relative luciferase activity was expressed as arbitrary units by normalizing firefly
luciferase activity to Renilla luciferase activity.
(B) KSHV ORF52 inhibits cGAS-induced IRF3 dimerization and phosphorylation. HEK293T-STING cells were transfected with expression plasmids as indicated.
Twenty-four hours after transfection, cell lysates were analyzed for IRF3 dimerization by native gel electrophoresis. IRF3 phosphorylation and expression levels of
the transfected genes were monitored by immunoblotting with antibodies.
(C) KSHV ORF52 inhibits cGAS-induced antiviral response. HEK293T-STING cells transfected with specified plasmids were infected with vesicular stomatitis
virus (VSV-GFP). The percentage of GFP-positive cells, as analyzed by FACS, is shown for each condition.
(D–F) ORF52 inhibits cGAS DNA sensing signaling in THP-1 cells. THP1 Lucia ISG cells harboring pEasiLV-ORF52 or pEasiLV-empty were untreated or induced
with 2 mg/ml doxycycline for 60 hr, then transfected with ISD45 or Poly(I:C) (2 mg/ml) (D and E), or infected with VACV or SEV (F). The activity of secreted Lucia
luciferase was determined, or cell lysates were harvested then analyzed for IRF3 dimerization and phosphorylation (E).
(G–I) TAT-ORF52 protein inhibits cGASDNA-sensing signaling in THP-1 cells. THP1 Lucia ISG cells were incubated with 1.25 mMor 2.5 mMTAT-ORF52 protein for
3 hr, then transfected with ISD45 or Poly(I: C) (2 mg/ml) (G and H) or infected with VACV or SEV (I). Analyses of luciferase activity or IRF3 dimerization were
performed as in (D)–(F). **p < 0.01 and ***p < 0.001; Student’s t test. See also Figures S1 and S2.
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Figure 2. ORF52 Inhibits cGAS Enzymatic
Activity
(A and B) ORF52 affects the cGAS-DNA-sensing
signaling pathway upstream of cGAMP. THP1
Lucia ISG cells harboring pEasiLV-ORF52 or
pEasiLV-empty were induced with 2 mg/ml doxy-
cycline for 60 hr, then transfected with ISD45 or
cGAMP (2 mg/ml). IRF3 dimerization was analyzed
(A) or the secreted Lucia activity was determined
(B) as in Figure 1.
(C) Coomassie blue staining of purified hcGAS and
ORF52 proteins.
(D and E) ORF52 inhibits hcGAS enzymatic activ-
ity. Purified hcGAS protein (1 mM) was incubated
with ISD45 (1 mM), [a-32P]-ATP, ATP, and GTP in
reaction buffer containing different amount of
ORF52 protein (0, 1, 2, or 4 mM). The reactions
were stopped at the indicated time by boiling for
5 min. Synthesis of cGAMP was analyzed by thin-
layer chromatography (TLC) (D), and the efficiency
of cGAMPproduction was plotted against time (E).
(F) ORF52 inhibits mouse cGAS activity. Mouse
cGAS (mcGAS; 1 mM) was used for the enzyme
assay and TLC as described in (D). ***p < 0.001;
Student’s t test.mediated by another cytosolic DNA sensor, AIM2 (Figures S3A
and S3B) (Bu¨rckstu¨mmer et al., 2009; Fernandes-Alnemri et al.,
2009; Hornung et al., 2009). The specific inhibition of cGAS
by ORF52 prompted us to investigate the possibility of an
interaction between the two proteins. Indeed, we found that
GST-ORF52 pulled down Flag-tagged hcGAS efficiently, but
not Flag-AIM2 under the same conditions (Figure 4A). The inter-
action between ORF52 and cGAS was evidently not dependent
on DNA or RNA, because treatment with Benzonase, an enzyme
that digests both DNA andRNA, or inclusion of ethidium bromide
(EB), had little effect on it (Figure 4B). Importantly, ORF52 and
cGAS also interact with each other in cells, as revealed by their
coimmunoprecipitation (Figure 4C) and subcellular colocaliza-
tion (Figure S3C). To further study their interactions, we mapped
the interaction domains using a series of internal 10 aa deletion
mutants of GST-ORF52 in GST pull-down assays and found
that loss of aa 111–120 in ORF52 (ORF52 D111–120) abolished
its binding to cGAS (Figure 4D), which was confirmed by coim-
munoprecipitation assays (Figure S3D). This deletion also
compromised the inhibition of cGAS by ORF52 (Figure 3D).
The K68/69A and D111–120 double mutant further reduced
inhibition of cGAS (Figure 3D), supporting the idea that ORF52
blocks cGAS activity in part through their interaction. When
expressed ectopically in THP-1 cells, ORF52 inhibited DNA-336 Cell Host & Microbe 18, 333–344, September 9, 2015 ª2015 Elsevier Inc.induced dimerization and phosphory-
lation of IRF3, but ORF52 mutants defi-
cient in cGAS- or DNA-binding exhibited
reduced inhibition (Figure 4E). Similar re-
sults were obtained in HEK293T/STING
cells (Figure 4F), and in THP-1 cells trans-
fected with TAT-ORF52 WT or mutant
protein (Figures S3E–S3G). These results
corroborate our in vitro assays, suggest-
ing that optimal inhibition of cGAS activityrequires both the cGAS-binding and DNA-binding properties
of ORF52.
Interestingly, the cGAS-binding mutant, ORF52 D111–120,
also shows weakened DNA binding activity similar to that of
K68/69A (Kd of 2.23 versus 2.21 mM) (Figure S4A), making it
difficult to distinguish the contributions of protein-protein and
protein-DNA interactions from the loss of cGAS inhibition. We
therefore mapped regions of cGAS involved in its interaction
with ORF52. Our results showed that regions between aa
1–160 and aa 212–382 were involved in binding to ORF52
(Figure S4B). Consistently, we found that ORF52 inhibited the
activity of the full-length cGAS more efficiently than the trun-
cated form (aa 161–522) (Figures S4C–S4E).
ORF52 Homologs Also Inhibit cGAS
ORF52 is a gammaherpesvirus-specific tegument protein (Bortz
et al., 2003; Johannsen et al., 2004; O’Connor and Kedes, 2006;
Zhu et al., 2005) and shares a high degree of conservation
among them (Figure S5A). To investigate whether ORF52 homo-
logs from other gammaherpesviruses also inhibit cGAS activity,
we expressed them in bacteria and purified them to homogeneity
(Figure S5B). Our in vitro enzymatic assay showed that these
ORF52 homologs also inhibited cGAS activity (Figure 5A), and
that they inhibited cGAS-dependent activation of IRF3 in cells
Figure 3. ORF52 Binding to DNA Is Required for Its Inhibition of cGAS Activity
(A) ORF52 affects the kinetics of cGAS-dependent cGAMP production. In vitro enzyme assay was performed as in Figure 2D with 2-fold serial dilutions of ISD45
(starting from 30 mM, from right to left) in the presence or absence of ORF52 (4 mM) for 2 hr. cGAMP production was detected by TLC, and the initial reaction
velocity was plotted against substrate concentration together with least-squares fit to the Michaelis-Menten equation.
(B) Fluorescence polarization analysis of hcGAS or ORF52 binding to DNA. FAM-labeled ISD45was incubated with different amounts of ORF52 or hcGAS protein,
and the Kd values were obtained from least-squares fit to a hyperbolic binding isotherm.
(C) Mutagenesis of ORF52 reveals that K68/69 are critical for its binding to DNA. GST-ORF52 protein was pulled down by dsDNA cellulose beads, and then eluted
with the indicated salt concentration (upper panel). The GST-ORF52 charge-deficient mutants were pulled down by dsDNA cellulose beads, eluted with 300 mM
NaCl, separated by SDS-PAGE, and visualized by Coomassie staining.
(D) ORF52 mutants deficient in cGAS/DNA-binding display reduced inhibition of cGAS activity. In vitro enzyme assay was performed in the presence or absence
of the indicated amount of ORF52wild-type ormutant proteins, and the percentage of cGAMPproduction was plotted for each protein concentration (right panel).
See also Figure S3.
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Figure 4. Interaction between ORF52 and
cGAS Underlies the Specific Inhibition of
cGAS-Mediated Signaling
(A) ORF52 binds to cGAS, but not AIM2. Purified
GST-ORF52 or GST proteins were used to pull
down lysates of HEK293T cells transiently ex-
pressing Flag-hcGAS or Flag-hAIM2. The inter-
action was detected by western blot analysis
using anti-FLAG antibody.
(B) The interaction between ORF52 and hcGAS
is not dependent on DNA. HEK293T cell lysate
expressing Flag-hcGAS was untreated, or treated
with Benzonase (0.1 U/ml or 1 U/ml) or EB, for 2 hr
on ice, followed by pull-down assay with GST-
ORF52 or GST protein. The interacted protein
was detected with anti-FLAG antibody (left panel).
The lysate DNA was separated by agarose gel
electrophoresis and stained with EB (right panel).
(C) ORF52 interacts with cGAS in vivo. Cells
were transfected as indicated and lysates were
immunoprecipitated with anti-ORF52 antibody,
followed by western blot analysis with anti-FLAG
and anti-ORF52 antibodies. Arrows indicate heavy
chains of IgG.
(D) Mapping the region of ORF52 required for
its interaction with hcGAS. Serial 10 aa deletion
mutants of GST-ORF52 were used to pull
down lysates of HEK293T cells transiently ex-
pressing Flag-hcGAS. Interaction was detected
by western blot analysis with anti-FLAG antibody,
and comparable protein level was confirmed by
Ponceau S.
(E) THP1 Lucia ISG cells harboring ORF52-
pEasiLV (WT or mutants) were mock treated
or induced with doxycycline for 60 hr, followed
by mock transfection or transfection with ISD45.
IRF3 dimerization was analyzed by native gel
electrophoresis.
(F) HEK293T/STING cells were transfected
with expression plasmids of cGAS and ORF52
WT/mutants as indicated. Twenty-four hours
after transfection, cell lysates were analyzed for
IRF3 dimerization by native gel electrophoresis.
IRF3 phosphorylation and expression levels of the
transfected genes were analyzed by western blot.
See also Figures S3 and S4.(Figures 5B and 5C). Moreover, these homologs all bound to
DNA (Figures 5D and S5C) and to cGAS (Figures 5E and S5D)
comparably, suggesting an evolutionarily-conserved mecha-
nism for the inhibition of cGAS within gammaherpesviruses.
KSHV Can Elicit a cGAS DNA Sensing Response that Is
Counteracted by ORF52
KSHV infection triggered the innate immune response in
HEK293T cells reconstituted with cGAS and STING, as evi-
denced by increased pIRF3 signal (Figure 6A). Phosphorylation338 Cell Host & Microbe 18, 333–344, September 9, 2015 ª2015 Elsevier Inc.of IRF3 was most prominent at early
times (2 and 6 hr) but decreased at later
times (12 and 24 hr) postinfection (hpi).
The phosphorylation was apparently
dependent on the cGAS-STING DNA-
sensing pathway, because the signalwas not detected unless both cGAS and STING were expressed
(Figure 6B). Our results are consistent with increasing evidence
that herpesviral DNA can be sensed by cGAS (Sun et al., 2013;
Li et al., 2013b; Yang et al., 2015). To determine the effect of
ORF52 on sensing of KSHV by cGAS, we infected HEK293T/
cGAS-STING cells with KSHV wild-type (BAC16-wt) or an
ORF52 null mutant virus (BAC16-Stop52). As shown in Figure 6C,
the ORF52 null virus induced a higher level of pIRF3 at 6
and 12 hpi, indicating a role of ORF52 in inhibiting the innate
immune response to KSHV primary infection. The ORF52 protein
Figure 5. Homologs of ORF52 in Other
Gammaherpesviruses Also Inhibit cGAS
Activity
(A) ORF52 homologs, but not AIM2 DNA binding
domain (AIM2DPYD), can inhibit hcGAS activity.
The enzyme assay and TLC were performed as
in Figure 2D, but with ORF52 homologs or
AIM2DPYD.
(B and C) ORF52 homologs inhibit the cGAS-
induced IFN response. Experiments were per-
formed as described in Figures 1A and 1B, but
with ORF52 homologs.
(D) ORF52 homologs bind to dsDNA. dsDNA
cellulose beads were used to pull down His-
tagged ORF52 protein and glutaredoxin 1 (GRX1)
proteins, then the beads were boiled in 2 3
Laemmli loading buffer, and the eluted proteins
were analyzed by SDS-PAGE and Coomassie
staining.
(E) ORF52 homologs all bind to hcGAS. His-
ORF52 proteins were used to pull down lysates
of HEK293T cells expressing Flag-hcGAS, and
the input/eluates were probed with anti-FLAG or
anti-His antibody. See also Figure S5.delivered into cells from incoming virions apparently interacted
with cGAS (Figure 6D), suggesting that ORF52 may interfere
with cGAS during KSHV primary infection. When THP1 Lucia
ISG cells were infected with KSHV, an increase of luciferase ac-
tivity was observed, but this increase was abolished if cGASwas
knocked out by CRISPR/Cas9-mediated genome editing (Fig-
ures 6E and S6), providing evidence that KSHV is sensed by a
cGAS-dependent pathway. Importantly, there was an additional
increase of luciferase activity in cells infected with ORF52 null
virus (Figure 6F), confirming a role of ORF52 in inhibition of
cGAS-dependent responses during KSHV infection. We next
used human primary lymphatic endothelial cells (LECs), because
they are believed to be the target cells of KSHV and are highly
permissive to KSHV infection. KSHV infection of LECs caused
a noticeable increase in IFNb and ISG54 mRNA levels at 6 hpi,
(Figure 6G). In agreement with a role of ORF52 in inhibition
of cGAS-DNA sensing, a more dramatic increase of IFNb and
ISG54 mRNA levels was observed in LECs infected with
BAC16-Stop52 virus (Figure 6H). To determine whether activa-
tion of cGAS inhibits KSHV infection, we adopted a strategy
that has been used by Dr. Charles Rice’s group to systematically
examine the antiviral effect of hundreds of ISGs (Schoggins et al.,
2011; Schoggins et al., 2014). Among those ISGs, cGAS was
found to exert an antiviral effect on a variety of DNA and RNA
viruses, including MHV68. We transduced LECs with either
cGAS-expressing or control luciferase-expressing lentivirus,
then infected them with GFP-labeled KSHV virions. As shown
in Figure 6I, we found that ectopic expression of cGAS sup-
pressed the permissiveness of primary endothelial cells to
KSHV infection, indicating that cGAS exerts a potent antiviral
effect on KSHV. Together, these experiments demonstrate that
KSHV triggers a cGAS-dependent immune response during pri-
mary infection, and that ORF52 plays a critical role in inhibiting
this response.Cell Host &DISCUSSION
The genomic DNA of herpesviruses accounts for about 10%–
20% of virion mass (Heine et al., 1974; Nealon et al., 2001),
constituting a significant PAMP within the incoming virions.
Although herpesviruses deliver and replicate their genome in
the nucleus, the incoming DNA could be recognized by cGAS
(Horan et al., 2013; Orzalli and Knipe, 2014; Paludan et al.,
2011; Sun et al., 2013; Yang et al., 2015). Stimulation of the
cGAS-cGAMP DNA-sensing pathway results in activation of
IRF3 and production of IFNs not only in infected cells but also
in neighboring cells, causing repression of viral replication,
elimination of virus-infected cells by apoptosis, and subsequent
activation of adaptive immune responses. Thus, it is intuitive
that herpesviruses should possess mechanisms to prevent the
sensing of their DNA. This would be especially true for KSHV,
because periodic lytic replication and de novo infection occur
naturally and are required for long-term persistence and patho-
genesis in its hosts. Indeed, a screening of KSHV ORFs revealed
that eight proteins substantially inhibited cGAS-STING-depen-
dent DNA-sensing signaling. Notably, five of these proteins,
ORF36, ORF45, ORF52, ORF55, and ORF64, have been shown
or predicted to be tegument proteins (Bortz et al., 2003; Johann-
sen et al., 2004; O’Connor and Kedes, 2006; Zhu et al., 2005).
Although these viral proteins could be involved in other aspects
of immune evasion, the presence of multiple antagonists of the
cGAS-STING pathway attests to the importance of preventing
recognition of virion-contained PAMPs, including viral DNA.
This also supports our previous observation that KSHV infection
induced only a mild antiviral effect in human primary fibroblast
cells, because the KSHV virion contains potent antagonists of
host innate antiviral immune responses (Zhu et al., 2010).
We demonstrated that ORF52 bound to DNA and to cGAS
inhibited cGAS-STING-dependent activation of IRF3 in cells,Microbe 18, 333–344, September 9, 2015 ª2015 Elsevier Inc. 339
Figure 6. KSHV ORF52 Antagonizes cGAS-
Dependent Induction of the Innate Immune
Response to Primary Infection
(A) HEK293T/cGAS-STING cells were infected by
KSHV. At the indicated time after infection, cell
lysates were analyzed by western blotting with the
indicated antibodies.
(B) KSHV primary infection and analysis of the
indicated cell lines was performed as in (A).
(C) HEK293T/cGAS-STING cells were infected by
KSHV BAC16-wt or BAC16-Stop52 mutant. At the
indicated time after infection, cell lysates were
analyzed by western blotting with the indicated
antibodies.
(D) Flag-cGAS/293T cells were infected with
KSHV at 50 genome copies/cell for 30 min, and
then cell lysates were prepared and immuno-
precipitated with anti-ORF52 4H4 antibody. The
immunocomplexes were analyzed by western blot
with indicated antibodies.
(E) cGAS was knocked out by CRISPR/Cas9-
mediated genome editing in THP1 Lucia ISG cells.
The knockout cell line and control were infected by
KSHV, and the activity of secreted Lucia luciferase
was assessed at 24 hpi.
(F) THP-1 Lucia ISG cells were infected by KSHV
BAC16-wt or BAC16-Stop52 mutant. Luciferase
activity was measured as in (E).
(G) LECs were mock treated or infected by KSHV
at 25, 50, or 100 genome copies/cell. RNAs were
isolated from cells and reverse transcribed. The
levels of IFNb and ISG54mRNAwere measured by
qRT-PCR at 6 hpi.
(H) LECs were infected by KSHV BAC16-wt or
BAC16-Stop52 at 50 copies/cell. The levels of
IFNb and ISG54 mRNA were measured as in (G).
(I) HUVECs or LECs were transduced with lentivi-
ruses as indicated. At 24 hr after transduction, they
were infected with BAC16-wt, followed by fixation
and FACS analyses of the GFP-positive cells the
next day. *p < 0.05 and **p < 0.01; Student’s t test.
See also Figure S6.and, most importantly, that ORF52 directly inhibited cGAS enzy-
matic activity. Although ORF52 binds to DNA, no known DNA
binding domain can be recognized. Unlike most DNA-binding
proteins that are usually localized in the nucleus, ORF52 is found
exclusively in the cytoplasm (Figure S3C; Sander et al., 2008), a
feature thatmight play an important role in the inhibition of cGAS.
Although the DNA-binding capacity of ORF52 is required for
inhibition of cGAS, it is apparently insufficient because OFR52
binds to DNA with less affinity than cGAS. Importantly, we found
ORF52 also bound to cGAS, but not to another cytosolic DNA
sensor, AIM2. This difference explains why ORF52 inhibits
cGAS-dependent activation of IRF3 but not AIM2-dependent
inflammasome responses. The fact the AIM2 DNA binding
domain cannot inhibit cGAS either in vitro or in vivo reaffirms
that simple sequestration of DNA appears not to be an effective
mechanism of inhibiting cGAS. Interestingly, ORF52 binds to340 Cell Host & Microbe 18, 333–344, September 9, 2015 ª2015 Elsevier Inc.both the catalytic domains aa 212–382
and aa 1–160, which appears to be a reg-
ulatory domain of cGAS (Sun et al., 2013).Unfortunately, because the DNA- and cGAS-binding properties
of ORF52 are seemingly inseparable, the extent to which they
contribute to the inhibition of cGAS is unknown. Nevertheless,
our data suggest both DNA-binding and cGAS-binding are
required for inhibition of cGAS by ORF52. Further structural
studies of ORF52 interaction with cGAS and/or DNA will be
crucial for delineation of the underlying molecular mechanisms.
Although ORF52 efficiently inhibits cGAS activity, ORF52 null
mutant viruses only resulted in a moderate increase in IRF3-
dependent responses. This is not surprising, because KSHV is
known to encode multiple genes of immune modulatory func-
tions, and because our initial screening found at least eight
ORFs that interfered with the cGAS-STING signaling pathway.
Some of these have been shown to subvert innate immunity by
means of diverse mechanisms. But, unlike ORF52 that targets
cGAS directly, these KSHV proteins appear to interfere with
downstream signaling components of cGAS, including IRFs. For
example, K9 (vIRF-1), ORF36, and ORF45 all interfere with acti-
vation of IRFs (Gao et al., 1997; Hwang et al., 2009; Liang et al.,
2012; Lin et al., 2001; Sathish and Yuan, 2011; Zhu et al., 2002);
ORF64, a viral deubiquitinase (DUB), interferes with ubiquitina-
tion of the key components of innate immune signaling pathways
(Inn et al., 2011; Wang et al., 2013). Because many viral immune-
modulatory proteins are known to interfere with different aspects
of immune responses, we expect that further studies will reveal
additional roles and mechanisms by which these KSHV proteins
subvert the host antiviral immune responses. The rich presence
of antagonists of pattern recognition receptors (PRRs) provides
an ideal mechanism to suppress activation of sensing of virion-
contained PAMPs, thus blocking the upregulation of the next
wave of ISGs.
Although ORF52 is known as an abundant tegument protein in
virions (Bortz et al., 2007; Johannsen et al., 2004; O’Connor and
Kedes, 2006; Zhu et al., 2005), its precise function has remained
elusive (Anderson et al., 2014; Bortz et al., 2007; Wang et al.,
2012). It is conserved among gammaherpesviruses but not
in alpha or beta herpesviruses. Significantly, we found that
ORF52 homologs also bound to cGAS and DNA and inhibited
cGAS activity directly, suggesting that inhibition of cGAS
by virion-contained ORF52 is a conserved mechanism for
gammaherpesviruses.
Viral inhibitors of RNA sensing have been extensively studied,
and several viral strategies to avoid dsRNA-mediated activation
of RNA sensors have been characterized (Gack, 2014; Yo-
neyama et al., 2015; Zinzula and Tramontano, 2013). We show
here that ORF52 is a viral inhibitor of the principal cytosolic
DNA sensor, cGAS. We propose to name it KSHV inhibitor of
cGAS (KicGAS). A growing number of viruses and bacteria
have been shown to be sensed by cGAS (Dai et al., 2014; Gao
et al., 2013a; Lam et al., 2014; Li et al., 2013b; Collins et al.,
2015; Hansen et al., 2014; Storek et al., 2015; Wassermann
et al., 2015; Watson et al., 2015). Among hundreds of ISGs eval-
uated by Dr. Charles Rice’s group, cGAS is one of the few that
exhibit potent antiviral effects on diverse groups of both DNA
and RNA viruses (Schoggins et al., 2011, 2014). Viruses other
than gammaherpesviruses are conceivably expected to encode
cGAS antagonists. A recent study has revealed that the HSV-1
VP22 core domain has limited structural and sequence homol-
ogy to MHV68 ORF52 (Hew et al., 2015). Because VP22 is
also an abundant tegument protein (Spear and Roizman,
1972), it would be interesting to examine whether VP22 can
inhibit cGAS, and how other large DNA viruses, such as alpha
and beta herpesviruses and poxviruses, overcome cGAS-
dependent DNA sensing. Collectively, our results have provided
insights into the study of viral strategies to antagonize cGAS
DNA-sensing signaling. The sensing of self and foreign DNA is
delicately regulated (Ablasser et al., 2014; Konno et al., 2013;
Liang et al., 2014), and the dysregulation of DNA sensing is
associated with several human autoimmune diseases, such as
systemic lupus erythematosus and Aicardi-Goutie`res syndrome
(Ahn and Barber, 2014). Therefore, further delineation of
the mechanisms by which KicGAS inhibits cGAS will aid in our
understanding of this pathway, and may facilitate the develop-
ment of therapeutics to treat or prevent diseases in which this
pathway is dysregulated.Cell Host &EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
HEK293T and HeLa cells were cultured under 5% CO2 at 37
C in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum
(FBS) and antibiotics. iSLK-puro cells carrying BAC16 wild-type or mutants
were cultured in DMEM containing 10% FBS, 50 mg/ml G418, 1 mg/ml puromy-
cin, and 500 mg/ml hygromycin (Brulois et al., 2012; Myoung and Ganem,
2011). Conditions for induction of lytic reactivation in these cells were
described previously (Fu et al., 2015). THP-1 and THP1 Lucia ISG cells
(InvivoGen) were cultured in RPMI containing 10% FBS, and antibiotics.
LECs and HUVECs were cultured in EBM-2 media supplemented with the
EGM-2 MV bullet in collagen type I-coated dishes. Transient transfections
were performed with Lipofectamine 2000 according to the manufacturer’s
protocol, or with polyethylenimine (PEI), or calcium chloride using standard
protocols.
Luciferase Reporter Assays
HEK293T/STING cells seeded on 24-well plates were transiently transfected
with 100 ng of the luciferase reporter plasmid together with a total of 300 ng
of various expression plasmids and/or empty vector controls using Effectene
Transfection Reagent (QIAGEN). As an internal control, 10 ng of pRL-TK
(Renilla luciferase) was transfected simultaneously. Luciferase assays were
then performed at 24 hr posttransfection according to the Promega Dual-
Luciferase Reporter Assay System protocol. The relative luciferase activity
was expressed as arbitrary units by normalizing firefly to Renilla luciferase
activity.
Induction of Immune Responses by Nucleic Acid Transfection
and Virus Infection
HEK293T or SLK cells were mock treated or transfected with ISD or Poly(I:C)
(2 mg/ml). THP1-Lucia ISG cells carrying ORF52-pEasiLV or Empty-pEasiLV
were untreated or treated with doxycycline (2 mg/ml) for 60 hr, then seeded
to new wells and either mock treated or transfected with ISD/Poly(I:C)
(2 mg/ml) or cGAMP (2 mg/ml; Figures 2A and 2B). Six hours posttransfection,
cell lysates were harvested and analyzed by native PAGE (to detect IRF3
dimerization) or western blot. Alternatively, the media was collected at 16 hr
posttransfection, and the activity of secreted Lucia luciferase was determined
by addition of QUANTI-Luc (Invivogen) and analysis with a luminometer. To
detect the immune response to virus infection, HEK293T cells were mock
infected or infected with VACV, or SEV. THP1-Lucia cells carrying ORF52-
pEasiLV or Empty-pEasiLV were mock treated or treated with doxycycline,
then infected with VACV or SEV. Analysis of IRF3 activation and luciferase
assay were performed as described above.
Protein Purification
TAT-ORF52 protein purification was performed according to Dr. S.F. Dowdy’s
group (Becker-Hapak and Dowdy, 2003). Further details, including methods
used to purify His-tagged cGAS andORF52, can be found in the Supplemental
Information.
TAT-ORF52 Protein Transduction
THP1-Lucia cells were incubated with TAT-ORF52 proteins (1.25 or 2.5 mM)
in serum-free media. After 3 hr, cells were washed with complete media
(RPMI + 10% FBS), then either transfected with ISD/Poly(I:C) or infected
with VACV/SEV virus as described above. Delivery of protein into cells was
confirmed by immunofluorescence staining using anti-ORF52 antibody.
GST Pull-Down Assay
GST-ORF52 ormutant proteins were bound to glutathione agarose beads, and
incubated for 3 hr with lysates fromHEK293T cells transiently expressing Flag-
cGAS or Flag-AIM2. The beads were washed three times each with whole-cell
lysis (WCL) buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% NP-40, 1 mM
sodium orthovanadate [Na3VO4], 40 mM-glycerophosphate, 1 mM sodium
fluoride, 10% glycerol, 5 mM EDTA, 5 mg/ml of aprotinin, 5 mg/ml of leupeptin,
5 mM benzamidine, and 1 mM PMSF) and 13 PBS, then mixed with an equal
volume of 23 Laemmli loading buffer, and boiled for 10 min. The input/eluatesMicrobe 18, 333–344, September 9, 2015 ª2015 Elsevier Inc. 341
were resolved by SDS-PAGE and analyzed by Coomassie staining and/or
western blot.In Vitro Enzyme Assay
cGAS protein was incubated with ISD45, 100 mMATP, 100 mMGTP, a32P-ATP
(10 mCi), and the indicated amount of ORF52 protein in reaction buffer at 37C
for the indicated time. The reaction was terminated by boiling for 5 min. Of
each sample, 1 mL was applied to a PEI-Cellulose F thin-layer chromatography
plate. Reaction products were resolved with 1 M (NH4)2SO4/1.5 M KH2PO4
(pH 3.8). Plates were dried at 80C for 10 min, and radiolabeled products
were detected by a Storm phosphorimager (GE Life Sciences). The signal
was analyzed with ImageQuant, and the data were fitted to a Michaelis-
Menten-like equation: Y = Vmax*[ISD45]/(EC50 + [ISD45]). The EC50 value of
DNA determined in this manner indicated the concentration of DNA at which
cGAS reaches its half-maximum activity. Detailed experimental procedures
are shown in the Supplemental Information.Double-Stranded DNA Cellulose Pull-Down Assay
dsDNA cellulose (Sigma, D8515) was incubated with purified GST-ORF52
or mutant proteins in buffer (50 mM Tris-HCl [pH 7.4], 100 mM NaCl, 1 mM
sodium orthovanadate [Na3VO4], 1 3 protease inhibitor cocktail, and 1 mM
PMSF) for 1 hr at 4C, then washed three times with the same buffer. The pro-
tein bound beads were eluted stepwise with 10 mM Tris-HCl (pH 7.4) buffer
containing different concentrations of NaCl (Figure 3C, upper panel), buffer
containing 300 mMNaCl (Figure 3C, lower panel), or with 23 Laemmli loading
buffer (Figure 5D). The input and eluted proteins were then applied to SDS-
PAGE and stained by Coomassie blue.Virus Stock Preparation and Infection
For KSHV, virus stock preparation, quantification, and infection were per-
formed as described previously (Fu et al., 2015). SEV was used at a final con-
centration of 50 HA units/ml. VACV was inactivated at 56C for 30 min before
usage and was used at an moi of 10. For vesicular stomatitis virus infection,
VSV-GFP was used at an moi of 1. Cells were analyzed by FACS at 48 hr
postinfection. Further details can be found in the Supplemental InformationQuantitative Real-Time PCR Analysis
LECs were mock treated or infected with KSHV for 6 hr. The mRNA was ex-
tracted, reverse transcribed, and mRNA levels determined by real-time PCR.
Expression levels were normalized to GAPDH expression and data are pre-
sented as fold induction over mock treatment control. More details can be
found in the Supplemental Information.CRISPR/Cas9-Mediated Genome Editing
Potential guide RNAs (gRNAs) targeting the first exon of cGAS were analyzed
using the CRISPR Design tool (crispr.mit.edu). Double-stranded oligos were
cloned into the lentiCRISPRv1 vector and cotransfected with packaging
plasmids into HEK293T cells. Lentiviral particles were collected and used to
transduce THP1 Lucia ISG cells. #2 and #13 represent two single-cell clones
with efficient cGAS knockout.More details regarding generation and validation
of these cell lines can be found in the Supplemental Information.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article at http://dx.doi.org/10.1016/j.
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